An Observational Study to Assess the Prevalence of Heart Failure in Type 2 Diabetes Patients
NCT ID: NCT04072523
Last Updated: 2022-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
621 participants
OBSERVATIONAL
2019-12-03
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort Study in Type 2 Diabetes in China
NCT01076023
Indian Phenotype Registry
NCT03363594
The Role of Insulin Resistance in Patients With Heart Failure and Type 2 Diabetes
NCT02559128
Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects
NCT02109835
Biomarkers as Predictors of Chronic Heart Failure in Patients With Type 2 Diabetes
NCT04941794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational Study Investigational Product NA
Patients : Type 2 Diabetic Patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with type 2 diabetes (as per ADA Criteria)
* Duration of diabetes for 1 year or more
* Willing to provide the informed consent
Exclusion Criteria
* Patients who were previously diagnosed with heart failure.
* Patients with evidence of valvular disease based on clinical judgement of the Principle Investigator (PI).
* Current treatment with digoxin.
* History of symptoms of peripheral artery disease, chronic obstructive pulmonary disease and arrhythmias.
* Patients diagnosed with stage III/IV CKD
* Diabetes other than type 2 diabetes mellitus.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Ahemdabad, Gujarat, India
Research Site
Rajkot, Gujarat, India
Research Site
Rohtak, Haryana, India
Research Site
Bangalore, Karnataka, India
Research Site
Bangalore, Karnataka, India
Research Site
Kochi, Kerala, India
Research Site
Mumbai, Maharashtra, India
Research Site
Delhi, New Delhi, India
Research Site
Delhi, New Delhi, India
Research Site
Amritsar, Punjab, India
Research Site
Chandigarh, Punjab, India
Research Site
Jalandhar, Punjab, India
Research Site
Ludhiana, Punjab, India
Research Site
Chennai, Tamil Nadu, India
Research Site
Chennai, Tamil Nadu, India
Research Site
Hyderabad, Telangana, India
Research Site
Hyderabad, Telangana, India
Research Site
Kanpur, Uttar Pradesh, India
Research Site
Kanpur, Uttar Pradesh, India
Research Site
Kolkata, West Bengal, India
Research Site
Kolkata, West Bengal, India
Research Site
Kolkata, West Bengal, India
Research Site
Kolkata, West Bengal, India
Research Site
Kolkata, West Bengal, India
Research Site
Delhi, , India
Research Site
Delhi, , India
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D1843R00300
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.